-- Cosmos Health (COSM) 週一宣布，其護肝保健品 Liv18 的第一階段生產已提前完成。 該公司表示，Liv18 的生產預計將於本月開始，隨後很快就會進入市場。 Cosmos 表示，基於在廣告、客戶獲取和業務拓展方面的計劃投入，以及其其他產品在美國市場取得的早期商業成功，Liv18 預計年收入將超過 500 萬美元，毛利率約為 75%。 該公司股價週一下跌超過 6%。
Price: $0.38, Change: $-0.03, Percent Change: -6.47%
Related Articles
Australia
Devon Energy Shares Rise After Tudor Pickering Holt Upgrade
Devon Energy (DVN) shares rose 1.9% in Monday trading after Tudor Pickering Holt upgraded the stock to buy from hold with a $63 price target.Intraday trading topped 5.66 million shares versus the daily average of 14.4 million.Price: $45.07, Change: $+0.84, Percent Change: +1.90%
$DVN
Australia
Plexus Shares Rise After Stifel Upgrade
Plexus (PLXS) shares rose 5% on Monday after Stifel upgraded the stock to buy from hold and boosted its price target to $250 per share from $200 earlier.Trading volume stood at over 199,500 shares compared with a daily average of 366,565.Price: $240.05, Change: $+11.41, Percent Change: +4.99%
$PLXS
Australia
TC Energy Shares Rise After Goldman Sachs Upgrade
TC Energy (TRP) shares rose 1.1% on Monday after Goldman Sachs upgraded the stock to neutral from sell.Trading volume stood at over 1.2 million shares compared with a daily average of nearly 2.6 million.Price: $61.34, Change: $+0.72, Percent Change: +1.19%
$TRP